Basic information
Biomarker: intra-tumoralCD8(+)
Full name: intra-tumoralCD8(+)
Clinical application: prognosis (favorable)
Histology type: endometrioid endometrial carcinoma
Cohort characteristics
Country: Netherlands
Region: Groningen
Followed up time : 4.4 years (range 0-21.5)
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 368 | EC | 368 |
Sample information
Sample type : tissue
Clinical method: immunohistochemistry
Expression pattern : upregulated
Biomarker characteristic: intra-tumoralCD8(+)/FoxP3(+) ratio
Disease information
Subgroup 1 name: Low
Subgroup 2 name: High
Subgroup 2 number: 149
